New CAR-T cells that attack atypical solid cancer antigens
Carina Biotech is developing CAR-T cells targeted at molecular markers found on a broad range of cancer types but with little expression on healthy cells.
Carina has lead CAR-T cells that have been shown to kill a wide range of cancer cells in vitro and in animal models.
We hope to ultimately develop CAR-T therapies that have potent cancer-killing power yet result in few off-cancer side-effects. Our researchers are currently progressing a number of CAR-T cells through pre-clinical testing.